| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―08 |
COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response |
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu |
| 2 |
[GO] |
2024―Jul―08 |
COVID-19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
| 3 |
[GO] |
2024―Jul―04 |
Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study |
J. S. Rech, A. Cohen, P. Bartolucci, A. Santin, C. Chantalat Auger, L. Affo, S. Le Jeune, J. B. Arlet, P. Y. Boëlle, O. Steichen |
| 4 |
[GO] |
2024―Jun―13 |
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy |
Yeong Jer Lim, Victoria Ward, Anthony Brown, Eloise Phillips, Barbara Kronsteiner, Tom Malone, Daisy Jennings, Saoirse Healy, Stephanie Longet, Timothy James, Paul Thomson, Liam Farrell, Melanie Oates, Richard Jackson, Andrew Morrison, Matthew Burns, Miles Carroll, Paul Klenerman, Lance Turtle, Dean Naisbitt, Malcolm Rhodes, Kate Robinson, Simona Gatto, Moya Young, Kim Linton, Toby A. Eyre, David W. Eyre, Susanna Dunachie, Eleanor Barnes, Andrew Pettitt |
| 5 |
[GO] |
2024―Apr―18 |
Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia |
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu |
| 6 |
[GO] |
2024―Mar―20 |
COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias |
Michail Spanoudakis, Deniz Yilmaz Karapinar, David Dale, Audrey Anna Bolyard, Emily Tran, Jelena Roganovic, Marije Bartels, Suncica Kapor, Daniela Guardo, Joanne Yacobovich, Christer Nilsson, Valentino Bezzerri, Marco Cipolli, Anna Pegoraro, Emil Aleksov, Margarita Guenova, Carlo Dufour, Francesca Fioredda, Helen A. Papadaki, Jan Palmblad |
| 7 |
[GO] |
2024―Feb―08 |
Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID-19 prevention |
Julia Trepl, Chloé Pasin, Dominik Schneidawind, Nicolas J. Mueller, Markus G. Manz, Andriyana K. Bankova, Irene A. Abela |
| 8 |
[GO] |
2023―Nov―28 |
Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre review |
Sara Stefani, Noora Buti, Alice C. J. Hart, Deena Paul, Naghma Rizvi, Vashti Ragoonanan, Camelia Vladescu, Richard Szydlo, Christine Ademokun, A. J. Gerard Jansen, Nichola Cooper |
| 9 |
[GO] |
2023―Nov―21 |
Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era |
Ulrike Bacher, Evgenii Shumilov, Thomas Pabst |
| 10 |
[GO] |
2023―Nov―15 |
Characteristics and outcomes of COVID-19 in Chinese immune thrombocytopenia patients: A prospective cohort study |
Yunfei Chen, Jiaying Liu, Shuai Shao, Zhen Song, Yueshen Ma, Yuanyuan Tuo, Lijun Fang, Yanmei Xu, Bingqi Xu, Wenjing Gu, Xuan Cao, Jia Chen, Yu Yang, Panjing Wang, Jing Zhang, Yuan Xu, Dandan Yu, Pengxiao Hou, Ke Meng, Zhirong Li, Guanyu Liu, Xinmiao Qu, Lulu Ji, Renchi Yang, Lei Zhang |
| 11 |
[GO] |
2023―Nov―15 |
Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies |
Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Kenji Sakizono, Yuya Nagai, Nobuhiro Hiramoto, Noboru Yonetani, Tadakazu Kondo, Chisato Miyakoshi, Asako Doi, Takayuki Ishikawa |
| 12 |
[GO] |
2023―Oct―27 |
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada |
Inna Y. Gong, Anca Prica, Zharmaine Ante, Andrew Calzavara, Monika K. Krzyzanowska, Simron Singh, Adam Suleman, Matthew C. Cheung, Michael Crump |
| 13 |
[GO] |
2023―Oct―13 |
Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy |
Emil R. Kyvsgaard, Caroline Riley, Michael Roost Clausen, Mads Harsløf, Line Dam Heftdal, Carsten U. Niemann, Kirsten Grønbæk, Martin Hutchings, Simon Husby |
| 14 |
[GO] |
2023―Oct―12 |
Prolonged platelet hyperactivity after COVID-19 infection |
Noriko Nara, Mie Shimizu, Masahiro Yamamoto, Tomoki Nakamizo, Azusa Hayakawa, Ken Johkura |
| 15 |
[GO] |
2023―Oct―05 |
Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study |
Takaya Ichikawa, Tomokazu Tamura, Mutsumi Takahata, Takashi Ishio, Makoto Ibata, Ikumi Kasahara, Koichiro Minauchi, Satoshi Yamamoto, Takanori Teshima, Takasuke Fukuhara |
| 16 |
[GO] |
2023―Oct―03 |
Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study |
Lukas Kevličius, Karolis Šablauskas, Kazimieras Maneikis, Dovilė Juozapaitė, Ugnė Ringelevičiūtė, Vilmantė Vaitekėnaitė, Birutė Davainienė, Guoda Daukėlaitė, Dominika Vasilevska, Mindaugas Stoškus, Ieva Narkevičiūtė, Violeta Sivickienė, Kęstutis Rudaitis, Mantas Minkauskas, Daniel Naumovas, Tumas Beinortas, Laimonas Griškevičius |
| 17 |
[GO] |
2023―Sep―12 |
Lymphoplasmacytic lymphoma presenting cold agglutinin syndrome: Clonal expansion of KMT2D and IGHV4-34 mutations after COVID-19 |
Kiyohito Hayashi, Daisuke Koyama, Yuki Sato, Masahiko Fukatsu, Takayuki Ikezoe |
| 18 |
[GO] |
2023―Sep―06 |
Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL |
Yandong Shen, Jane A. Freeman, Ian Kerridge, Paul Downe, Kartik Naidu, Juliette Holland, Stephen P. Mulligan |
| 19 |
[GO] |
2023―Aug―24 |
Impairment of platelet function in both mild and severe COVID-19 patients |
Mariangela Scavone, Claudia Ghali, Mariagrazia Calogiuri, Matteo Sala, Elena Bossi, Tatiana Mencarini, Silvia Bozzi, Bianca Clerici, Simone Birocchi, Antonella Fioretti, Valeria Bono, Norma Maugeri, Giulia Marchetti, Marco Cattaneo, Gian Marco Podda |
| 20 |
[GO] |
2023―Aug―23 |
Transient increase in platelet counts associated with COVID-19 infection during TPO-RA as the second-line treatment in children with ITP |
Zhifa Wang, Xiaoling Cheng, Nan Wang, Jinxi Meng, Jingyao Ma, Zhenping Chen, Runhui Wu |
| 21 |
[GO] |
2023―Aug―07 |
Early COVID-19 treatment with Sotrovimab in high-risk Beta-thalassemia: Real-life case-series, state of the art and new perspectives |
Lorenza Torti |
| 22 |
[GO] |
2023―Jul―31 |
Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies |
Ulrike Bacher, Evgenii Shumilov, Thomas Pabst |
| 23 |
[GO] |
2023―Jul―13 |
Early treatment for COVID-19 in patients with haematological malignancies: Much more than a recommendation! |
Francesco Passamonti, Alessandra Bandera |
| 24 |
[GO] |
2023―Jul―06 |
High prevalence of persistent COVID-19-related health anxiety and social restriction in patients with haematological disorders |
G. Agarwal, S. Varghese, M. Francis, J. Willan |
| 25 |
[GO] |
2023―Jul―05 |
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination |
Christopher L. Pinder, Dylan Jankovic, Thomas A. Fox, Amy Kirkwood, Louise Enfield, Aljawharah Alrubayyi, Emma Touizer, Rosemarie Ford, Rachael Pocock, Jin-Sup Shin, Joseph Ziegler, Kirsty J. Thomson, Kirit M. Ardeshna, Dimitra Peppa, Laura E. McCoy, Emma C. Morris |
| 26 |
[GO] |
2023―Jun―24 |
Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration |
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Wataru Hojo, Hironori Sakai, Sakuya Matsumoto, Marika Watanabe, Akihito Kitao, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Taiji Koyama, Yoshiaki Nagatani, Shiro Kimbara, Yoshinori Imamura, Naomi Kiyota, Mitsuhiro Ito, Hironobu Minami |
| 27 |
[GO] |
2023―Jun―12 |
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes |
Justin Loke, Vinit Upasani, Charlotte Gaskell, Sonia Fox, Rachel Fletcher, Catherine Thomas, Louise Hopkins, Anita Kumari, Tina Tang, Emily Yafai, Rebecca Boucher, Victoria Homer, Arpad Toth, Y. L. Tracey Chan, Katie Randall, Tom Rider, Jenny O'Nions, Victoria Drew, Arvind Pillai, Moez Dungarwalla, Duncan Murray, Anjum Khan, Farooq Wandroo, Sally Moore, Pramila Krishnamurthy, Ya-Wen Jessica Huang, Steve Knapper, Jenny Byrne, Rui Zhao, Charles Craddock, Helen Parry, Paul Moss, Simon J. Stanworth, David M. Lowe |
| 28 |
[GO] |
2023―Jun―08 |
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease |
Hirotomo Nakahara, Narayanaiah Cheedarla, Hans P. Verkerke, Suneethamma Cheedarla, Shang-Chuen Wu, Jeanne E. Hendrickson, Andres Chang, Morgan L. McLemore, Fuad El Rassi, John D. Roback, Andrew S. Neish, Ross M. Fasano, Sean R. Stowell |
| 29 |
[GO] |
2023―Jun―01 |
Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort |
Carla Minoia, Lucia Diella, Tommasina Perrone, Giacomo Loseto, Carmen Pelligrino, Immacolata Attolico, Crescenza Pasciolla, Valentina Totaro, Maria Stella De Candia, Vito Spada, Felice Clemente, Michele Camporeale, Francesco Di Gennaro, Attilio Guarini, Pellegrino Musto, Annalisa Saracino, Davide Fiore Bavaro |
| 30 |
[GO] |
2023―May―23 |
The evolution of the
COVID
-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron |
Olufunke Y. Martin, Stefanie Margulies, Barbara Speller-Brown, Suvankar Majumdar, Deepika S. Darbari, Andrew D. Campbell |
| 31 |
[GO] |
2023―Mar―21 |
Burden of
COVID-19
disease and vaccine coverages in Apulian splenectomized patients: A retrospective observational study |
Francesco Paolo Bianchi, Pasquale Stefanizzi, Donato Rizzi, Noemi Signorile, Eustachio Cuscianna, Antonio Daleno, Giovanni Migliore, Silvio Tafuri |
| 32 |
[GO] |
2023―Mar―02 |
Mortality and burden of
post-COVID
-19 syndrome have reduced with time across
SARS-CoV
-2 variants in haematology patients |
John Willan, Gaurav Agarwal, Nicola Bienz |
| 33 |
[GO] |
2023―Feb―21 |
Outcome of early treatment of
SARS-CoV
-2 infection in patients with haematological disorders |
Malgorzata Mikulska, Diletta Testi, Chiara Russo, Elisa Balletto, Chiara Sepulcri, Linda Bussini, Chiara Dentone, Federica Magne, Sílvia Policarpo, Caterina Campoli, Filippo Miselli, Alessandro Cilli, Chiara Ghiggi, Sara Aquino, Carmen Di Grazia, Maddalena Giannella, Daniele Roberto Giacobbe, Antonio Vena, Anna Maria Raiola, Francesca Bonifazi, Pierluigi Zinzani, Michele Cavo, Roberto Lemoli, Emanuele Angelucci, Pierluigi Viale, Matteo Bassetti, Michele Bartoletti |
| 34 |
[GO] |
2023―Feb―17 |
Correction to “Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for
COVID
-19: The
GIMEMA EMATO
-0321 study”MarascoV, PiciocchiA, CandoniA, PaganoL, GuidettiA, MustoP, et al. Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study. Br J Haematol. 2022;199(1):54-60. |
|
| 35 |
[GO] |
2023―Feb―10 |
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (
R-MIV
) in patients with primary
CNS
lymphoma including recent
COVID
-19 pandemic experience |
Beata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, Michal Osowiecki, Lukasz Targonski, Lidia Poplawska, Robert Konecki, Martyna Kotarska, Marcin Szymanski, Anna Borawska, Monika Swierkowska, Anna Dabrowska-Iwanicka, Agnieszka Druzd-Sitek, Ewa Paszkiewicz-Kozik, Ewa Mroz-Zycinska, Joanna Tajer, Elzbieta Wojciechowska-Lampka, Wlodzimierz Osiadacz, Grzegorz Rymkiewicz, Grazyna Lapinska, Marta Wojewodzka-Mirocha, Wojciech Michalski, Jan Walewski |
| 36 |
[GO] |
2022―Dec―24 |
Autoimmune haemolytic anaemia and immune thrombocytopenia following
SARS-CoV
-2 and
non-SARS-CoV
-2 vaccination: 32 Years of passive surveillance data |
Jeremy W. Jacobs, Garrett S. Booth, Juliana Guarente, Danielle Schlafer, Leon Zheng, Brian D. Adkins |
| 37 |
[GO] |
2022―Dec―21 |
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia |
Enrico Tiacci, Alessandro Mancini, Monia Marchetti, Gianna Maria D'Elia, Anna Candoni, Alessandro Morotti, Alessandra Romano, Alessandro Gozzetti, Alessandro Broccoli, Luca De Carolis, Riccardo Bruna, Maria Chiara Tisi, Carmine Selleri, Monia Capponi, Daniele Vallisa, Chiara Cattaneo, Matteo Giovanni Della Porta, Alessandro Busca, Brunangelo Falini, Massimo Massaia, Lorenza Berté, Alessandro Pulsoni, Paolo Rivela, Paolo Corradini, Francesco Passamonti |
| 38 |
[GO] |
2022―Dec―09 |
Immune correlates of protection by vaccine against
SARS-CoV
-2 in patients with chronic lymphocytic leukaemia |
Daniele Sorcini, Filomena De Falco, Marco Gargaro, Silvia Bozza, Valerio Guarente, Valeria Cardinali, Arianna Stella, Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Chiara Rompietti, Erica Dorillo, Clelia Geraci, Angela Esposito, Roberta Arcaleni, Silvia Capoccia, Maria Grazia Mameli, Alessandro Graziani, Lorenzo Moretti, Alessandra Cipiciani, Carlo Riccardi, Antonella Mencacci, Francesca Fallarino, Emanuela Rosati, Paolo Sportoletti |
| 39 |
[GO] |
2022―Nov―22 |
Clinical utility of haematological inflammatory biomarkers in predicting 30-day mortality in hospitalised adult patients with COVID-19 |
Ahmed Embaby, Mohamed Gaber Hamed, Huda Ebian, Lobna A. El-Korashi, Mohammad Walaa, Eman M. Abd el-Sattar, Amr Shaaban Hanafy, Shimaa Abdelmoneem |
| 40 |
[GO] |
2022―Nov―16 |
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation |
Andriyana K. Bankova, Chloé Pasin, Alice Huang, Caroline Cicin-Sain, Selina Epp, Annette Audige, Nicolas J. Mueller, Jakob Nilsson, Oliver Vilinovszki, Gayathri Nair, Nathan Wolfensberger, Philipp Hockl, Urs Schanz, Alexandra Trkola, Roger Kouyos, Barbara Hasse, Annelies S. Zinkernagel, Markus G. Manz, Irene A. Abela, Antonia M. S. Müller |
| 41 |
[GO] |
2022―Nov―10 |
Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease |
Laure Joseph, Anne Corbasson, Sandra Manceau, Djamal Khimoud, Benoit Meunier, Geoffrey Cheminet, François Lefrere, Anne-Sophie Jannot, Estelle Lu, Jean-Benoît Arlet |
| 42 |
[GO] |
2022―Nov―08 |
Antibody status following booster vaccination against
SARS-CoV
-2 virus in patients with haematologic malignancies |
Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Ayumi Kuzume, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Takeshi Yamashita, Hiroyuki Takamatsu, Kosei Matsue |
| 43 |
[GO] |
2022―Oct―07 |
Coronavirus disease 2019 (
COVID
-19): Focus on peripheral blood cell morphology |
Gina Zini, Giuseppe d'Onofrio |
| 44 |
[GO] |
2022―Oct―05 |
Remission of extranodal
NK
/T-cell lymphoma, nasal type, after
SARS-CoV
-2 vaccination |
Mengxiang Chen, Fu Ouyang, Tao Wu, Yunfei Hu, Yan Du, Yunhong Huang |
| 45 |
[GO] |
2022―Sep―21 |
Clinical outcomes and immune responses to
SARS-CoV
-2 vaccination in severe aplastic anaemia |
Roma V. Rajput, Xiaoyang Ma, Kristin L. Boswell, Martin Gaudinski, Ingelise Gordon, Laura Novik, Emma M. Groarke, Jennifer Lotter, Jeanine Superata, Olga J. Rios, Ivana Darden, Bob C. Lin, Nazaire Jean-Baptiste, Robin Carroll, Christopher Moore, Jessica Trost, Mursal Naisan, Jacquelyn Willis, Leonid Serebryannyy, Jennifer L. Wang, Madhu Prabhakaran, Sandeep R. Narpala, Richard A. Koup, Adrian McDermott, Colin O. Wu, Neal S. Young, Bhavisha A. Patel |
| 46 |
[GO] |
2022―Sep―05 |
Induction of robust humoral immunity against
SARS-CoV
-2 after vaccine administration in previously infected haematological cancer patients |
Cinzia Borgogna, Riccardo Bruna, Gloria Griffante, Licia Martuscelli, Marco De Andrea, Daniela Ferrante, Andrea Patriarca, Abdurraouf Mokhtar Mahmoud, Maghalie Anais Marie Ucciero, Valentina Gaidano, Monia Marchetti, Davide Rapezzi, Michele Lai, Mauro Pistello, Marco Ladetto, Massimo Massaia, Gianluca Gaidano, Marisa Gariglio |
| 47 |
[GO] |
2022―Aug―26 |
Central venous catheter-related bloodstream infections in patients with haematological malignancies during the
SARS-CoV
-2 pandemic |
Enrico Schalk, Timo Schmitt, Jens Panse, Eva Fiegle, Jan-Hendrik Naendrup, Martin Schmidt-Hieber, Boris Böll, Marcus Hentrich, Daniel Teschner, Dimitrios Mougiakakos |
| 48 |
[GO] |
2022―Aug―10 |
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group |
Sara Steffanoni, Teresa Calimeri, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Luca Arcaini, Sridhar Chaganti, Marianna C. Sassone, Alvaro Alencar, Daniele Armiento, Ilaria Romano, Jorg Dietrich, Gilad Itchaki, Riccardo Bruna, Nicola S. Fracchiolla, Laura Arletti, Adriano Venditti, Stephen Booth, Pellegrino Musto, Khê Hoang Xuan, Tracy T. Batchelor, Kate Cwynarski, Andrés J. M. Ferreri |
| 49 |
[GO] |
2022―Jun―03 |
The impact of COVID-19 on related-donor allogeneic stem cell harvest processes: A British Society of Blood and Marrow Transplantation and Cellular Therapy survey |
Julia Wolf, Julia Lee, Rachel Pearce, Marie Wilson, John A. Snowden, Kim Orchard |
| 50 |
[GO] |
2022―May―17 |
Anti-severe acute respiratory syndrome coronavirus-2
adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers |
Eleonora Petito, Elisabetta Colonna, Emanuela Falcinelli, Anna Maria Mezzasoma, Enrica Cesari, Elisa Giglio, Tiziana Fiordi, Fabio Almerigogna, Alfredo Villa, Paolo Gresele |
| 51 |
[GO] |
2022―May―10 |
Antibody responses to
SARS-CoV
-2 vaccination in patients with acute myeloid leukaemia and high risk
MDS
on active anti-cancer therapies |
W. Y. Chan, C. Zhu, E. Sanchez, R. Gupta, A. K. Fielding, A. Khwaja, E. M. Payne, J. O’Nions |
| 52 |
[GO] |
2022―Apr―12 |
Can B cell-deficient patients rely on COVID-19 vaccine-induced T cell immunity? |
Tanaya Shree |
| 53 |
[GO] |
2022―Mar―14 |
Immune response and adverse events after vaccination against
SARS-CoV
-2 in adult patients with transfusion-dependent thalassaemia |
Polyxeni Delaporta, Evangelos Terpos, Elena E. Solomou, Sentiljana Gumeni, Evangelia Nitsa, Filia Apostolakou, Dimitra Kyriakopoulou, Ioannis Ntanasis-Stathopoulos, Ioannis Papassotiriou, Ioannis P. Trougakos, Meletios A. Dimopoulos, Antonis Kattamis |
| 54 |
[GO] |
2022―Mar―09 |
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: An observational study |
Masashi Nishikubo, Yoshimitsu Shimomura, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Hiroharu Imoto, Ryusuke Yamamoto, Yuya Nagai, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Akiko Matsushita, Chisato Miyakoshi, Asako Doi, Takayuki Ishikawa |
| 55 |
[GO] |
2022―Mar―07 |
Rituximab-treated lymphoma patients develop strong CD8 T-cell responses following COVID-19 vaccination |
Jon Riise, Saskia Meyer, Isaac Blaas, Adity Chopra, Trung T Tran, Marina Delic-Sarac, Malu Lian Hestdalen, Ellen Brodin, Even Holth Rustad, Ke-Zheng Dai, John Torgils Vaage, Lise Sofie Haug Nissen-Meyer, Fredrik Sund, Karin F. Wader, Anne T. Bjornevik, Peter A. Meyer, Gro O. Nygaard, Marton König, Sigbjørn Smeland, Fridtjof Lund-Johansen, Johanna Olweus, Arne Kolstad |
| 56 |
[GO] |
2022―Feb―28 |
Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies |
Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Haruna Muraki, Masanobu Morioka, Takanori Teshima, Takeshi Kondo |
| 57 |
[GO] |
2022―Feb―17 |
Depletion of
CD38
-positive regulatory T cells by
anti-CD38
monoclonal antibodies induces a durable response to
SARS-CoV
-2 vaccination in patients with plasma cell dyscrasia |
Toshiki Terao, Takashi Naduka, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Kosei Matsue |
| 58 |
[GO] |
2022―Feb―17 |
Serological response to SARS-CoV-2 mRNA-LNP vaccine in patients with multiple myeloma: a negative impact of CD38
+
Treg? |
Frédéric Baron, Jo Caers, Stéphanie Humblet-Baron |
| 59 |
[GO] |
2022―Feb―12 |
The Impact of B-cell Directed Therapy on SARS-CoV-2 Vaccine Efficacy in CLL |
Chaitra Ujjani, Mazyar Shadman, Ryan C. Lynch, Brian Tu, Philip A. Stevenson, Caitlin Grainger, Haiying Zhu, Joshua A. Hill, Meei-Li Huang, Leslie Nielsen, Christina Poh, Tyler Sorenson, Ajay K. Gopal, Edus H. Warren, Brian G. Till, Sydney Lee, Daria Gausman, Stephen D. Smith, Ted Gooley, Alex Greninger |
| 60 |
[GO] |
2022―Feb―02 |
Association of Rhesus Factor Blood Type with Risk of SARS-CoV-2 Infection and COVID-19 Severity |
Jeffrey L Anderson, Heidi T. May, Stacey Knight, Tami L Bair, Benjamin D Horne, Kirk U Knowlton |
| 61 |
[GO] |
2022―Jan―25 |
Platelets modulate CD4
+
T Cell function in Covid-19 Through A PD-L1 Dependent Mechanism |
Ana Paletta, Facundo Di Diego García, Augusto Varese, Fernando Erra Diaz, Julián García, Juan Carlos Cisneros, Guillermina Ludueña, Ignacio Mazzitelli, Andrea Pisarevsky, Gonzalo Cabrerizo, Álvaro López Malizia, Alejandra G. Rodriguez, Nicolás Lista, Yesica Longueira, Juan Sabatté, Jorge Geffner, Federico Remes Lenicov, Ana Ceballos |
| 62 |
[GO] |
2022―Jan―25 |
BNT162b2 mRNA COVID-19 vaccine booster induces seroconversion in patients with B-cell non-Hodgkin lymphoma who failed to respond to two prior vaccine doses |
Irit Avivi, Efrat Luttwak, Esther Saiag, Tami Halperin, Shira Haberman, Ariel Sarig, Sivan Levi, Anat Aharon, Yair Herishanu, Chava Perry |
| 63 |
[GO] |
2022―Jan―25 |
Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titers |
O. Šušol, B. Hájková, H. Zelená, R. Hájek |
| 64 |
[GO] |
2022―Jan―22 |
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response |
Karthik Ramasamy, Ross Sadler, Sally Jeans, Paul Weeden, Sherin Varghese, Alison Turner, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Gordon Cook, Chara Kyriakou, Mark Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, Muhammad K Javaid |
| 65 |
[GO] |
2022―Jan―14 |
The impact of COVID-19 vaccination on patients with a history of heparin induced thrombocytopenia |
U. Faruqi, K. White, N. Murray, J. Cutler, K. Breen |
| 66 |
[GO] |
2022―Jan―14 |
COVID-19 Vaccine Response in Chronic Lymphocytic Leukaemia is More Than Just Seroconversion |
Clare Sun |
| 67 |
[GO] |
2022―Jan―14 |
Response to vaccination against SARS-CoV-2 in 168 patients with Waldenström macroglobulinemia: a French Innovative Leukemia Organization (FILO) study |
Cécile Tomowiak, Véronique Leblond, Kamel Laribi, Marine Baron, Christian Puppinck, Paulette Gérard, Elodie Courret, Guy Gorochov, Delphine Sterlin, Olivier Tournilhac, Pierre Morel, Florence Cymbalista, Damien Roos-Weil |
| 68 |
[GO] |
2021―Dec―28 |
Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner |
Yohann Garnier, Livia Claude, Patricia Hermand, Evely Sachou, Aurélie Claes, Kassandra Desplan, Bassel Chahim, Pierre-Marie Roger, Frédéric Martino, Yves Colin, Caroline Le Van Kim, Véronique Baccini, Marc Romana |
| 69 |
[GO] |
2021―Dec―28 |
COVID-19 Vaccine Failure in Chronic Lymphocytic Leukaemia and Monoclonal B-Lymphocytosis; Humoral and Cellular Immunity |
Yandong Shen, Jane A. Freeman, Juliette Holland, Ann Solterbeck, Kartik Naidu, Asha Soosapilla, Paul Downe, Catherine Tang, Ian Kerridge, Lucinda Wallman, Nenna Van Bilsen, Vanessa Milogiannakis, Anouschka Akerman, Gabriela Martins Costa Gomes, Kerrie Sandgren, Anthony L Cunningham, Stuart Turville, Stephen P. Mulligan |
| 70 |
[GO] |
2021―Dec―28 |
Post-COVID-19 syndrome in patients with haematological disorders who have survived infection with severe acute respiratory syndrome coronavirus-2 |
John Willan, Lidice Hernandez, Harley Katz, Nicola Gray, Nicola Bienz |
| 71 |
[GO] |
2021―Dec―10 |
Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia |
Mahmoud I. Elbadry, Ahmed Tawfeek, Mohammed G. Abdellatif, Eman H. Salama, Ahmed Abudeif, Hany Mahmoud, Mohamed Ezeldin, Rasha Mokhtar Abdelkareem, Usama M. Rashad |
| 72 |
[GO] |
2021―Dec―07 |
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response |
Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner, Magdalena Benda, Luciano Severgnini, Andreas Volgger, Theresia Lang, Michele Atzl, Minh Huynh, Klaus Gasser, Claudia Grabher, Sylvia Mink, Peter Fraunberger, Ulf Petrausch, Bernd Hartmann, Thomas Winder |
| 73 |
[GO] |
2021―Dec―01 |
Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting? |
Salyka Sengsayadeth, Larisa Broglie, Bipin N. Savani |
| 74 |
[GO] |
2021―Nov―16 |
A case of severe aplastic anaemia after SARS-CoV-2 vaccination |
Nicola Cecchi, Juri Alessandro Giannotta, Wilma Barcellini, Bruno Fattizzo |
| 75 |
[GO] |
2021―Nov―12 |
Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection |
Scott J. C. Pallett, Rachel Wake, Jonathan Youngs, Cassie Pope, Ngee Keong Tan, Joshua Taylor, Lois Hawkins, Adam A. Witney, Kenneth G. Laing, Irene M. Monahan, Melek Akay, Alison Cox, Elisabetta Groppelli, Peter Kelleher, Paul Miller, Tihana Bicanic |
| 76 |
[GO] |
2021―Nov―11 |
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy |
Stephen Booth, Helen M. Curley, Csilla Varnai, Roland Arnold, Lennard Y. W. Lee, Naomi A. Campton, Gordon Cook, Karin Purshouse, James Aries, Andrew Innes, Lucy B. Cook, Oliver Tomkins, Helen S. Oram, Michael Tilby, Austin Kulasekararaj, David Wrench, Saoirse Dolly, Tom Newsom-Davies, Ruth Pettengell, Abigail Gault, Sam Moody, Sajjan Mittal, Mohammed Altohami, Tania Tillet, Jack Illingworth, Leena Mukherjee, Jane Apperly, John Ashcroft, Neil Rabin, Jonathan Carmichael, Jean-Baptiste Cazier, Rachel Kerr, Gary Middleton, Graham P. Collins, Claire Palles |
| 77 |
[GO] |
2021―Oct―29 |
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients |
Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Vladislav Litachevsky, Itzchak Levy, Liraz Olmer, Yaniv Lusitg, Abraham Avigdor, Arnon Nagler, Avichai Shimoni, Galia Rahav |
| 78 |
[GO] |
2021―Oct―28 |
Is COVID-19 less severe in CML patients than in those with other haematological cancers? |
Simone Claudiani |
| 79 |
[GO] |
2021―Oct―19 |
T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies |
Vincenzo Marasco, Cristiana Carniti, Anna Guidetti, Lucia Farina, Martina Magni, Rosalba Miceli, Ludovica Calabretta, Paolo Verderio, Silva Ljevar, Fabio Serpenti, Daniele Morelli, Giovanni Apolone, Giuseppe Ippolito, Chiara Agrati, Paolo Corradini |
| 80 |
[GO] |
2021―Oct―15 |
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report |
Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, Immacolata Attolico, Sara Barulli, Micaela Bergamaschi, Gianni Binotto, Monica Bocchia, Massimiliano Bonifacio, Giovanni Caocci, Isabella Capodanno, Fausto Castagnetti, Francesco Cavazzini, Elena Crisà, Monica Crugnola, Maria Stella De Candia, Chiara Elena, Carmen Fava, Sara Galimberti, Antonella Gozzini, Gabriele Gugliotta, Tamara Intermesoli, Alessandra Iurlo, Gaetano La Barba, Roberto Latagliata, Sabrina Leonetti Crescenzi, Luciano Levato, Giuseppina Loglisci, Alessandro Lucchesi, Luigiana Luciano, Francesca Lunghi, Debora Luzi, Alessandra Malato, Maria Cristina Miggiano, Michele Pizzuti, Patrizia Pregno, Davide Rapezzi, Giovanna Rege-Cambrin, Gianantonio Rosti, Sabina Russo, Rosaria Sancetta, Anna Rita Scortechini, Federica Sorà, Paolo Sportoletti, Fabio Stagno, Agostino Tafuri, Mario Tiribelli, Robin Foà, Giuseppe Saglio |
| 81 |
[GO] |
2021―Oct―13 |
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors |
Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J. Chavda, Emma Dowling, Nuno Correia, Catherine S. Y. Lecat, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Jonathan Sive, Charalampia Kyriakou, Ashutosh Wechalekar, Rakesh Popat, Neil Rabin, Eleni Nastouli, Kwee L. Yong, Ke Xu |
| 82 |
[GO] |
2021―Oct―09 |
Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study |
Deepa J. Arachchillage, Indika Rajakaruna, Ian Scott, Mihaela Gaspar, Zain Odho, Winston Banya, Aikaterini Vlachou, Graziella Isgro, Lenka Cagova, Joshua Wade, Lucy Fleming, Mike Laffan, Richard Szydlo, Stephane Ledot, Rachel Jooste, Alain Vuylsteke, Hakeem Yusuff |
| 83 |
[GO] |
2021―Oct―09 |
Conflicting impacts of tocilizumab and colchicine in COVID-19-associated coagulop |
Suhair Abdeen, Rami Abu-Fanne, Khalil Bdeir, Emad Maraga, Mohamed Higazi, Douglas B. Cines, Samuel N. Heyman, Abd Al-Roof Higazi |
| 84 |
[GO] |
2021―Sep―21 |
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies |
Thomas A. Fox, Amy A. Kirkwood, Louise Enfield, Maeve O'Reilly, Suzanne Arulogun, Shirley D'Sa, Jenny O'Nions, Janki Kavi, Evan Vitsaras, William Townsend, Siobhan O. Burns, Satyen H. Gohil, Kate Cwynarski, Kirsty J. Thomson, Mahdad Noursadeghi, Robert S. Heyderman, Tommy Rampling, Kirit M. Ardeshna, Laura E. McCoy, Emma C. Morris |
| 85 |
[GO] |
2021―Sep―16 |
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine |
Maria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Despina Fotiou, Eleni-Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Ioannis P. Trougakos, Efstathios Kastritis, Meletios-Athanasios Dimopoulos |
| 86 |
[GO] |
2021―Sep―15 |
Refusing blood transfusions from COVID-19-vaccinated donors: are we repeating history? |
Jeremy W. Jacobs, Lorin A. Bibb, Bipin N. Savani, Garrett S. Booth |
| 87 |
[GO] |
2021―Sep―14 |
The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey |
Rhys Hall, John Meenan, Diana Mihalca, Alvin Katumba, Saket Badle, Dede-Kossi Osakonor, Oloruntoyin Bello-Sanyaolu, Funmilayo Orebayo, Natasha Lewis, Basabi Chatterjee, Stephanie Coughlin, Dimitris A. Tsitsikas |
| 88 |
[GO] |
2021―Sep―09 |
Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study |
Deepa J. Arachchillage, Indika Rajakaruna, Zain Odho, Christina Crossette-Thambiah, Phillip L. R. Nicolson, Lara N. Roberts, Caroline Allan, Sarah Lewis, Renu Riat, Philip Mounter, Ceri Lynch, Alexander Langridge, Roderick Oakes, Nini Aung, Anja Drebes, Tina Dutt, Priyanka Raheja, Alison Delaney, Sarah Essex, Gillian Lowe, David Sutton, Claire Lentaigne, Zara Sayar, Mari Kilner, Tamara Everington, Susie Shapiro, Raza Alikhan, Richard Szydlo, Michael Makris, Michael Laffan |
| 89 |
[GO] |
2021―Aug―30 |
Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response |
Carla Schenker, Cédric Hirzel, Laura N. Walti, Sacha S. Zeerleder, Martin Andres, Alban Ramette, Maria T. Barbani, Franziska Suter-Riniker, Andreas Holbro, Tobias Tritschler |
| 90 |
[GO] |
2021―Aug―27 |
A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK |
Alexandros Rampotas, Edmund Watson, Kieran Burton, Quentin A. Hill, Sue Pavord |
| 91 |
[GO] |
2021―Aug―04 |
Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients |
Magdalena Benda, Beatrix Mutschlechner, Hanno Ulmer, Claudia Grabher, Luciano Severgnini, Andreas Volgger, Patrick Reimann, Theresia Lang, Michele Atzl, Minh Huynh, Klaus Gasser, Ulf Petrausch, Peter Fraunberger, Bernd Hartmann, Thomas Winder |
| 92 |
[GO] |
2021―Aug―02 |
Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia |
Paul Saultier, Laetitia Ninove, Sarah Szepetowski, Mathilde Veneziano, Sandrine Visentin, Vincent Barlogis, Paola Mariela Saba Villarroel, Abdennour Amroun, Marie Loosveld, Xavier de Lamballerie, Hervé Chambost |
| 93 |
[GO] |
2021―Jul―29 |
Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy |
Wei Yee Chan, Emilie Sanchez, Selina J. Chavda, Catherine S. Y. Lecat, Louise Ainley, Ke Xu, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Charalampia Kyriakou, Jonathan Sive, Ashutosh Wechalekar, Rakesh Popat, Neil Rabin, Lydia Lee, Eleni Nastouli, Kwee L. Yong |
| 94 |
[GO] |
2021―Jul―27 |
Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination |
Mouna Sassi, Linda Khefacha, Rihem Merzigui, Rim Rakez, Sarra Boukhriss, Mohamed A. Laatiri |
| 95 |
[GO] |
2021―Jul―17 |
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies |
Francesco Passamonti, Alessandra Romano, Marco Salvini, Francesco Merli, Matteo G. Della Porta, Riccardo Bruna, Elisa Coviello, Ilaria Romano, Roberto Cairoli, Roberto Lemoli, Francesca Farina, Adriano Venditti, Alessandro Busca, Marco Ladetto, Massimo Massaia, Antonio Pinto, Luca Arcaini, Agostino Tafuri, Francesco Marchesi, Nicola Fracchiolla, Monica Bocchia, Daniele Armiento, Anna Candoni, Mauro Krampera, Mario Luppi, Valeria Cardinali, Sara Galimberti, Chiara Cattaneo, Elettra Ortu La Barbera, Roberto Mina, Francesco Lanza, Giuseppe Visani, Pellegrino Musto, Luigi Petrucci, Francesco Zaja, Paolo A. Grossi, Lorenza Berté, Livio Pagano, Paolo Corradini, Enrico Derenzini, Monia Marchetti, Anna M. Scattolin, Alessandro Corso, Patrizia Tosi, Filippo Gherlinzoni, Carlo Gambacorti Passerini, Michele Cavo, Carmen Fava, Mauro Turrini, Carlo Visco, Patrizia Zappasodi, Michele Merli, Barbara Mora, Alessandro M. Vannucchi |
| 96 |
[GO] |
2021―Jul―11 |
Immature platelets in COVID-19 infection |
Robert W. Maitta |
| 97 |
[GO] |
2021―Jul―06 |
Experts’ views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease |
Uri Hamiel, Alina Kurolap, Ian J. Cohen, Noa Ruhrman-Shahar, Tova Hershkovitz, Claus Niederau, Ari Zimran, Shoshana Revel-Vilk, Majdolen Istaiti, Maria Domenica Cappellini, Hagit Baris Feldman |
| 98 |
[GO] |
2021―Jun―27 |
Cold agglutinin disease after COVID-19 vaccine |
Shaima Al Aoun, Ibraheem Motabi |
| 99 |
[GO] |
2021―Jun―25 |
Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine |
Valerio De Stefano, Marcello Candelli, Elena Rossi, Francesco Franceschi |
| 100 |
[GO] |
2021―Jun―16 |
The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 study |
Christina Crossette-Thambiah, Pip Nicholson, Indika Rajakaruna, Alexander Langridge, Zara Sayar, Maria Rita Perelta, Sarah Essex, Roderick Oakes, Philip Mounter, Sarah Lewis, Tina Dutt, Ian Scott, NiNi Aung, Susie Shapiro, Mike Laffan, Deepa RJ Arachchillage |
| 101 |
[GO] |
2021―Jun―16 |
Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients |
Daniel Welder, Haekyung Jeon-Slaughter, Bilal Ashraf, Sung-Hee Choi, Weina Chen, Ibrahim Ibrahim, Taha Bat |
| 102 |
[GO] |
2021―Jun―16 |
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms |
Onima Chowdhury, Hannah Bruguier, Garry Mallett, Nikolaos Sousos, Kirsty Crozier, Caroline Allman, David Eyre, Sheila Lumley, Marie Strickland, Christina Simoglou Karali, Lauren Murphy, Alex Sternberg, Katie Jeffery, Adam J Mead, Andy Peniket, Bethan Psaila |
| 103 |
[GO] |
2021―Jun―16 |
Primary Haemophagocytic Lymphohistiocytosis (Chédiak-Higashi Syndrome) triggered by acute SARS-CoV-2 infection in a 6-week-old infant |
M Lange, T Linden, HL Müller, AM Flasskuehler, H Koester, K Lehmberg, S Ledig, S Ehl, A Heep, F Beske |
| 104 |
[GO] |
2021―Jun―11 |
COVID-19 and Immunothrombosis: emerging understanding and clinical management |
Rebecca J. Shaw, Charlotte Bradbury, Simon T. Abrams, Guozheng Wang, Cheng-Hock Toh |
| 105 |
[GO] |
2021―Jun―11 |
Immunothrombosis: a COVID-19 concerto |
George Goshua, Ayesha Butt, Alfred I. Lee |
| 106 |
[GO] |
2021―Jun―11 |
Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine |
Quentin Scanvion, Marc Lambert, Eric Hachulla, Louis Terriou |
| 107 |
[GO] |
2021―Jun―09 |
Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts |
Conor McCafferty, Suelyn Van Den Helm, Natasha Letunica, Chantal Attard, Vasiliki Karlaftis, Tengyi Cai, Slavica Praporski, Ella Swaney, David Burgner, Melanie Neeland, Kate Dohle, Nigel W. Crawford, Luisa Clucas, Shidan Tosif, Vera Ignjatovic, Paul Monagle |
| 108 |
[GO] |
2021―Jun―08 |
Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19 |
Pratik A. Patel, Stacey A. Lapp, Gabrielle Grubbs, Venkata V. Edara, Christina A. Rostad, Claire L. Stokes, Melinda G. Pauly, Evan J. Anderson, Anne Piantadosi, Mehul S. Suthar, Surender Khurana, Himalee S. Sabnis |
| 109 |
[GO] |
2021―Jun―07 |
Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT) |
Sandheeah Ramdeny, Ailidh Lang, Sara Al-Izzi, Alexander Hung, Imran Anwar, Poornima Kumar |
| 110 |
[GO] |
2021―Jun―07 |
Rectus sheath and retroperitoneal haematomas in patients with Coronavirus 2019 infection |
Phoebe Hazenberg, Symeon Lechareas, Marcelo Vasquez Rios, Miriam Taegtmeyer, Richard McWilliams, Tina Dutt |
| 111 |
[GO] |
2021―Jun―04 |
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia |
Patrick Harrington, Katie J. Doores, Deepti Radia, Amy O’Reilly, Ho Pui Jeff Lam, Jeffrey Seow, Carl Graham, Thomas Lechmere, Donal McLornan, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire Harrison, Hugues Lavallade |
| 112 |
[GO] |
2021―Jun―02 |
Exacerbation of immune thrombocytopenia following Covid-19 vaccination |
David J. Kuter |
| 113 |
[GO] |
2021―May―30 |
Alpha-defensins: risk factor for thrombosis in COVID-19 infection |
Suhair Abdeen, Khalil Bdeir, Rami Abu-Fanne, Emad Maraga, Mohamed Higazi, Nigar Khurram, Michael Feldman, Charuhas Deshpande, Leslie A. Litzky, Samuel N. Heyman, Kathleen T. Montone, Douglas B. Cines, Abd Al-Roof Higazi |
| 114 |
[GO] |
2021―May―30 |
Antithrombin III deficiency-induced coagulopathy in the context of COVID-19: a case series |
Andrew J. Gardner, Daniel J. Kirkin, Sancho Rodriguez-Villar, Gonzalo Leoz Abellanas, Alice Tee, Antonio Valentin |
| 115 |
[GO] |
2021―May―26 |
COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey |
Wilma Barcellini, Bruno Fattizzo, Juri A. Giannotta, Luisa Quattrocchi, Semra Aydin, Federica Barone, Cecilia Carbone, Fabrizio Pomponi, Elisabetta Metafuni, Eloise Beggiato, Simona Sica, Eros Di Bona, Francesco Lanza, Rosario Notaro, Anna P. Iori |
| 116 |
[GO] |
2021―May―26 |
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned |
Vania Munaretto, Vincenzo Voi, Giovanni Palazzi, Lucia Dora Notarangelo, Paola Corti, Valentina Baretta, Maddalena Casale, Angelica Barone, Daniela Cuzzubbo, Piera Samperi, Serena Tripodi, Fiorina Giona, Maurizio Miano, Agostino Nocerino, Gian Carlo Del Vecchio, Chiara Piccolo, Antonella Sau, Beatrice Filippini, Maria Luisa Casciana, Francesco Arcioni, Maddalena Migliavacca, Paola Saracco, Chiara Gorio, Simone Cesaro, Silverio Perrotta, Marco Zecca, Paola Giordano, Silvia Fasoli, Beatrice Coppadoro, Giovanna Russo, Laura Sainati, Raffaella Colombatti |
| 117 |
[GO] |
2021―May―24 |
Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis |
Birgitte Tholin, Waleed Ghanima, Gunnar Einvik, Bernt Aarli, Eivind Brønstad, Ole H. Skjønsberg, Knut Stavem |
| 118 |
[GO] |
2021―May―16 |
Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19 |
Gina Sangha, Kunaal Kaushik, Amelia Robinson, Thomas Ainge, Moez Dungarwalla, Arup Chakraborty |
| 119 |
[GO] |
2021―May―16 |
Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response |
Henry Wood, Austin G. Kulasekararaj |
| 120 |
[GO] |
2021―May―15 |
Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain |
María E. Mingot-Castellano, Patricia Alcalde-Mellado, Cristina Pascual-Izquierdo, Gloria Perez Rus, Aida Calo Pérez, María P. Martinez, Francisco J. López-Jaime, Lorena Abalo Perez, José R. Gonzalez-Porras, Fernanda López Fernández, Isabel S. Caparrós Miranda, Tomás J. González-López, María E. Moreno Beltrán, Rebeca Rubio Escuin, Reyes Jimenez Bárcenas |
| 121 |
[GO] |
2021―May―08 |
Preoperative patient blood management during the SARS-CoV-2 pandemic |
Katie Hands, Craig Taylor, Alwyn Kotzé, Toby Richards, Shruthi Narayan |
| 122 |
[GO] |
2021―May―02 |
Immune thrombocytopenic purpura after SARS-CoV-2 vaccine |
Marcello Candelli, Elena Rossi, Federico Valletta, Valerio De Stefano, Francesco Franceschi |
| 123 |
[GO] |
2021―Apr―30 |
COVID-19 infection in patients with severe aplastic anaemia |
Casey Paton, Liza Mathews, Emma M. Groarke, Olga Rios, Jennifer Lotter, Bhavisha A. Patel, Neal S. Young |
| 124 |
[GO] |
2021―Apr―15 |
Immune thrombocytopenia during the COVID-19 pandemic |
Eun-Ju Lee, Xinguang Liu, Ming Hou, James B. Bussel |
| 125 |
[GO] |
2021―Mar―25 |
The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey |
Stephen J. Quinn, Lesley A. Anderson, Lynne Lohfeld, Charlene M. McShane |
| 126 |
[GO] |
2021―Mar―15 |
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) |
Patrick Harrington, Claire N. Harrison, Richard Dillon, Deepti H. Radia, Katayoun Rezvani, Kavita Raj, Claire Woodley, Natalia Curto-Garcia, Jennifer O’Sullivan, Jamie Saunders, Shahram Kordasti, Sahra Ali, Hugues Lavallade, Donal P. McLornan |
| 127 |
[GO] |
2021―Feb―18 |
Unusual morphological abnormality of neutrophils in a patient with SARS-CoV-2 infection |
Praveen Sharma, Shano Naseem, Neelam Varma, Pankaj Malhotra |
| 128 |
[GO] |
2021―Feb―07 |
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies |
Eleonora Calabretta, Jose M. Moraleda, Massimo Iacobelli, Ruben Jara, Israel Vlodavsky, Peter O’Gorman, Antonio Pagliuca, Clifton Mo, Rebecca M. Baron, Alessio Aghemo, Robert Soiffer, Jawed Fareed, Carmelo Carlo-Stella, Paul Richardson |
| 129 |
[GO] |
2021―Feb―03 |
Convalescent plasma for COVID-19 - encouraging signals of efficacy |
Arturo Casadevall, Aaron A. R. Tobian |
| 130 |
[GO] |
2021―Feb―01 |
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study |
Alienor Xhaard, Constance Xhaard, Maud D’Aveni, Helene Salvator, Marie-Laure Chabi, Ana Berceanu, Tereza Coman, Yves Beguin, Yves Chalandon, Xavier Poiré, Michaël Loschi, Catherine Paillard, Benedicte Bruno, Patrice Ceballos, Jean-Hugues Dalle, Karin Bilger, Jacques-Olivier Bay, Marie Robin, Stephanie N’Guyen-Quoc, Marie-Therese Rubio |
| 131 |
[GO] |
2021―Jan―25 |
Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia |
Beatriz de la Cruz-Benito, María I. Rivas-Pollmar, María T. Álvarez Román, Roberto Trelles-Martínez, Monica Martín-Salces, Paula Lázaro-del Campo, Andrés Ramírez-López, Sara García-Barcenilla, Tamara Cebanu, Paula Acuña-Butta, Elena Monzón-Manzano, Elena González-Zorrilla, Victor Jiménez-Yuste, Nora V. Butta |
| 132 |
[GO] |
2021―Jan―23 |
Early mortality benefit with COVID-19 convalescent plasma: a matched control study |
Aarthi G. Shenoy, Aaron Z. Hettinger, Stephen J. Fernandez, Joseph Blumenthal, Valentina Baez |
| 133 |
[GO] |
2021―Jan―21 |
The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact |
Kim Orchard, Fiona L. Dignan, Julia Lee, Rachel Pearce, Monica Desai, Emma McFarlane, Angela Parkin, Peter Shearn, John A. Snowden |
| 134 |
[GO] |
2021―Jan―15 |
COVID-19-associated oxidative damage to red blood cells |
Muhammad Khakwani, Claire Horgan, Joanne Ewing |
| 135 |
[GO] |
2021―Jan―10 |
Impact of COVID-19 on red blood cell rheology |
Céline Renoux, Romain Fort, Elie Nader, Camille Boisson, Philippe Joly, Emeric Stauffer, Mélanie Robert, Sandrine Girard, Agnès Cibiel, Alexandra Gauthier, Philippe Connes |
| 136 |
[GO] |
2021―Jan―06 |
Are mushroom-shaped erythrocytes an indicator of COVID-19? |
Delphine Gérard, Safa Ben Brahim, Jean François Lesesve, Julien Perrin |
| 137 |
[GO] |
2021―Jan―02 |
SARS-CoV-2-induced remission of Hodgkin lymphoma |
Sarah Challenor, David Tucker |
| 138 |
[GO] |
2020―Dec―25 |
von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients |
Maxime Delrue, Virginie Siguret, Marie Neuwirth, Bérangère Joly, Nicolas Beranger, Damien Sène, Benjamin G. Chousterman, Sebastian Voicu, Philippe Bonnin, Bruno Mégarbane, Alain Stépanian |
| 139 |
[GO] |
2020―Dec―18 |
Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19 |
Thomas Hueso, Clémentine Bouchez, Flore Salviat, Stéphanie Foulon, Laurence Albiges, Arnaud Bayle, Emmanuelle Gallois, Véronique Vergé, Valérie Boige, Franck Griscelli, Fanny Pommeret, David Ghez |
| 140 |
[GO] |
2020―Dec―18 |
Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation |
Soracha E. Ward, Gerard F. Curley, Michelle Lavin, Helen Fogarty, Ellie Karampini, Natalie L. McEvoy, Jennifer Clarke, Maria Boylan, Razi Alalqam, Amy P. Worrall, Claire Kelly, Eoghan Barra, Siobhan Glavey, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Liam Townsend, Patrick W. Mallon, Jamie M. O'Sullivan, James S. O'Donnell, Niamh O'Connell, Kevin Ryan, Mary Byrne, Roger Preston, Dermot Kenny |
| 141 |
[GO] |
2020―Dec―18 |
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK) |
Faye A. Sharpley, Jemma Larham, Angus Haines, Faouzi Djebbari, Bing Tseu, Heather Leary, Grant Vallance, Fotios Panitsas, Lisa Ferguson, Pamela Roberts, Andrew Peniket, Sarah Gooding, Jaimal Kothari, Sally Moore, Karthik Ramasamy |
| 142 |
[GO] |
2020―Dec―13 |
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies |
Albrecht Betrains, Laurent Godinas, F. J. Sherida H. Woei-A-Jin, Wouter Rosseels, Yannick Van Herck, Natalie Lorent, Daan Dierickx, Veerle Compernolle, Geert Meyfroidt, Lore Vanderbeke, Valentijn Vergote, Katrien Lagrou, Peter Verhamme, Joost Wauters, Pieter Vermeersch, Timothy Devos, Piet Maes, Steven Vanderschueren |
| 143 |
[GO] |
2020―Dec―02 |
COVID-19 associated Kikuchi-Fujimoto disease |
Laura Stimson, Richard Stitson, Maria Bahhadi-Hardo, Edward Renaudon-Smith |
| 144 |
[GO] |
2020―Nov―25 |
Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials? |
Keith Gomez, Mike Laffan, Charlotte Bradbury |
| 145 |
[GO] |
2020―Nov―22 |
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial |
Marquita Camilleri, Jonathan Sive, William Wilson, Gavin Pang, Richard Jenner, Elizabeth Phillips, Rakesh Popat, Karthik Ramasamy, Ceri Bygrave, Tushhar Dadaga, Matthew Streetly, James Cavenagh, Mike Chapman, Sally Barrington, Lucy Pike, Roger Owen, Laura Clifton-Hadley, Kwee Yong |
| 146 |
[GO] |
2020―Nov―22 |
Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction |
Francesca Palandri, Daniela Bartoletti, Stefania Giaquinta, Federica D’Ambrosio, Giuseppe Auteri, Emanuele Sutto, Lucia Catani, Nicola Vianelli, Michele Cavo |
| 147 |
[GO] |
2020―Nov―20 |
SARS-CoV-2 persistence and non-protective immunity in infected haematological patients |
Karolina Akinosoglou, Foteini Paliogianni, Alexandros Spyridonidis, Argiris Symeonidis, Leonidas G. Alexopoulos, Dimitrios Ziazias, Alexandra Kouraklis-Symeonidis, Markos Marangos, Charalambos Gogos |
| 148 |
[GO] |
2020―Nov―20 |
SARS-CoV-2 screening for asymptomatic health care workers in UK stem cell transplant units |
Adrian J. C. Bloor, Fiona L. Dignan, Julia Lee, Kim H. Orchard |
| 149 |
[GO] |
2020―Nov―05 |
COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium |
Hana Morrissey, Patrick Ball, Anandadeep Mandal, Alan Nevil, Shankara Paneesha, Supratik Basu, Farheen Karim, Md Imran Hossain, Neil Phillips, Jahanzeb Khawaja, Jackie Stone, Duncan Murray, Katie Randall, Vidhya Murthy, Bhuvan Kishore, Manos Nikolousis, Guy Pratt, Jeff Neilson, Nick Pemberton, Farooq Wandroo |
| 150 |
[GO] |
2020―Oct―26 |
Impact of immunosuppression on mortality in critically ill COVID-19 patients |
Adrien Mirouse, Michaël Darmon, Lara Zafrani, Etienne Lengliné, Elie Azoulay |
| 151 |
[GO] |
2020―Oct―26 |
Response to ‘Impact of immunosuppression on mortality in critically ill COVID-19 patients’ |
Thomas A. Fox, Ethan Troy-Barnes, Amy A. Kirkwood, Wei Y. Chan, James W. Day, Selina J. Chavda, Emil A. Kumar, Kate David, Oliver Tomkins, Emilie Sanchez, Marie Scully, Asim Khwaja, Jonathan Lambert, Mervyn Singer, Claire Roddie, Emma C. Morris, Kwee L. Yong, Kirsty J. Thomson, Kirit M. Ardeshna |
| 152 |
[GO] |
2020―Oct―20 |
Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naïve chronic lymphocytic leukaemia: a case report |
George Nesr, Rincy Koshy, David Foldes, Huseini Kagdi |
| 153 |
[GO] |
2020―Oct―10 |
A left shift in the oxyhaemoglobin dissociation curve in patients with severe coronavirus disease 2019 (COVID-19) |
Dominik J. Vogel, Federico Formenti, Andrew J. Retter, Francesco Vasques, Luigi Camporota |
| 154 |
[GO] |
2020―Sep―23 |
Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection |
Dina Sheha, Mohamed El-Shayeb, Yara Eid, Mariam Amin, Alia Saeed, Dina Abdou, Tarek Aly, Sherief Samy, Rahma Elziaty, Sherihan Aboelyazed, Ahmed Osman, Aliaa Sheha |
| 155 |
[GO] |
2020―Sep―18 |
COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience |
Alexandra Pike, Petra Muus, Tahla Munir, Lindsay Mitchell, Louise Arnold, Kathryn Riley, Nicola Houghton, Briony Forrest, Jeanifer Gachev, Peter Hillmen, Morag Griffin |
| 156 |
[GO] |
2020―Aug―31 |
Haemoglobin oxygen affinity in patients with severe COVID-19 infection: Still unclear |
Gurgen Harutyunyan, Garnik Harutyunyan, Gagik Mkhoyan, Varsenik Harutyunyan, Suren Soghomonyan |
| 157 |
[GO] |
2020―Aug―28 |
COVID-19 and haemoglobin oxygen affinity: some clarity? |
Michael J. Shattock, Yvonne Daniel, Beverley J. Hunt, Andrew Retter, Katherine Henderson, Sarah Wilson, Claire C. Sharpe |
| 158 |
[GO] |
2020―Aug―07 |
Managing the front-line treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma during the COVID-19 outbreak |
B de la Cruz-Benito, P Lázaro-del Campo, A Ramírez-López, T de Soto-Álvarez, I Sánchez-Vadillo, E García-Pérez, A Dos Santos-Ortas, K Humala-Barbier, A López-de la Guía, G Casado-Abad, V Jiménez-Yuste, MA Canales-Albendea |
| 159 |
[GO] |
2020―Aug―03 |
Abnormal concentration of porphyrins in serum from COVID-19 patients |
Itxaso San Juan, Chiara Bruzzone, Maider Bizkarguenaga, Ganeko Bernardo-Seisdedos, Ana Laín, Rubén Gil-Redondo, Tammo Diercks, Jon Gil-Martínez, Pedro Urquiza, Eunate Arana, Marisa Seco, Aitor García de Vicuña, Nieves Embade, José M Mato, Oscar Millet |
| 160 |
[GO] |
2020―Aug―02 |
Alice in Wonderland of blood groups and COVID-19 |
Hisato Takagi |
| 161 |
[GO] |
2020―Jul―17 |
Clinical outcomes and risk factors for severe COVID-19 infection in patients with haematological disorders receiving chemo- or immunotherapy |
TA Fox, E Troy-Barnes, AA Kirkwood, WY Chan, J Day, SJ Chavda, EA Kumar, K David, O Tomkins, E Sanchez, M Scully, A Khwaja, J Lambert, M Singer, C Roddie, EC Morris, KL Yong, KJ Thomson, KM Ardeshna |
| 162 |
[GO] |
2020―Jul―17 |
Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients |
Kyung-Chan Park, Killian Donovan, Stuart Mckechnie, Narayan Ramamurthy, Paul Klenerman, Pawel Swietach |
| 163 |
[GO] |
2020―Jul―17 |
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients |
Silvia Bellesi, Elisabetta Metafuni, Stefan Hohaus, Elena Maiolo, Federica Marchionni, Simone D’Innocenzo, Marilena La Sorda, Manuela Ferraironi, Francesco Ramundo, Massimo Fantoni, Rita Murri, Antonella Cingolani, Simona Sica, Antonio Gasbarrini, Maurizio Sanguinetti, Patrizia Chiusolo, Valerio De Stefano |
| 164 |
[GO] |
2020―Jul―17 |
Transfusion demand in COVID-19 patients from the Korean population: a nationwide study in South Korea |
John Hoon Rim, Sang Ah Lee, Chang Hoon Han, Jongha Yoo |
| 165 |
[GO] |
2020―Jul―17 |
Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series |
Matthieu Mahévas, Guillaume Moulis, Emmanuel Andres, Etienne Riviere, Margaux Garzaro, Etienne Crickx, Vivien Guillotin, Marion Malphettes, Lionel Galicier, Nicolas Noel, Luc Darnige, Louis Terriou, Claire Guerveno, Mateo Sanchis-Borja, Thomas Moulinet, Benoit Meunier, Mikael Ebbo, Marc Michel, Bertrand Godeau |
| 166 |
[GO] |
2020―Jul―11 |
Varying Presentations and Favourable Outcomes of COVID-19 Infection in Children and Young Adults with Sickle Cell Disease: An Additional Case Series with Comparisons to Published Cases |
Abena Appiah-Kubi, Suchitra Acharya, Carolyn Fein Levy, Adrianna Vlachos, Gholamabbas Ostovar, Kristina Murphy, Antonella Farrell, Donna Brower, Jeffrey M. Lipton, Lawrence Wolfe, Banu Aygun |
| 167 |
[GO] |
2020―Jul―11 |
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study |
Paul J. Hengeveld, Aaram Omar Khader, Linda H.A. de Bruin, Inge G.P. Geelen, Eske A. van Baalen, Eva Jansen, Nathalie I. Bouwer, Ömer Balak, Jurgen A. Riedl, Anton W. Langerak, Peter E. Westerweel, Mark-David Levin |
| 168 |
[GO] |
2020―Jul―11 |
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection |
Katharine Orf, Srdan Rogosic, Daniel Dexter, Phil Ancliff, Saket Badle, Joe Brierley, Danny Cheng, Caroline Dalton, Garth Dixon, Pascale Du Pré, Louis Grandjean, Sara Ghorashian, Prabal Mittal, David O’Connor, Vesna Pavasovic, Anupama Rao, Sujith Samarasinghe, Ajay Vora, Alasdair Bamford, Jack Bartram |
| 169 |
[GO] |
2020―Jul―09 |
COVID-19 comorbidities, associated pro-coagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity? |
Jameel Inal |
| 170 |
[GO] |
2020―Jul―09 |
Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2 |
Lúcia Silla |
| 171 |
[GO] |
2020―Jul―08 |
Blood Component Use in Critical Care in Patients with COVID-19 Infection: A Single Centre Experience |
Andrew J Doyle, Anicee Danaee, Charlene I Furtado, Scott Miller, Tim Maggs, Susan E Robinson, Andrew Retter |
| 172 |
[GO] |
2020―Jul―08 |
CoVID-19 insights from transfusion medicine |
Willy A. Flegel |
| 173 |
[GO] |
2020―Jul―06 |
Effect of low or high doses of low molecular weight heparin on thrombin generation and other hemostasis parameters in COVID-19 critical patients |
Antonio Chistolini, Franco Ruberto, Francesco Alessandri, Cristina Santoro, Francesco Barone, Maria Cristina Puzzolo, Giancarlo Ceccarelli, Maria Lucia De Luca, Massimo Mancone, Domenico Alvaro, Fabio M. Pulcinelli, Maurizio Martelli, Robin Foà, Francesco Pugliese, Alida Albante, Francesco Alessandri, Domenico Alvaro, Guido Antonelli, Fabio Araimo-Morselli, Daniela Auricchio, Erminia Baldacci, Francesco Barone, Federico Bilotta, Matteo Brisciani, Katia Bruno, Alessandro Cappannoli, Vincenzo Cardinale, Giancarlo Ceccarelli, Paola Celli, Antonio Chistolini, Stella Consolo, Claudia Croce, Beatrice Crocitti, Mariaignazia Curreli, Gabriella D’Ettorre, Daniela De Lauri, Francesco De Lazzaro, Maria Lucia De Luca, Francesco Fedele, Antonietta Ferretti, Gioacchino Galardo, Lorena Giannetti, Stefano Ianni, Carmela Imperiale, Viviana Maestrini, Eugenia Magnanimi, Federica Maldarelli, Massimo Mancone, Maurizio Martelli, Sabina Martelli, Claudio Mastroianni, Teresa Messina, Sandra Olivieri, Agnese Pallotta, Elisa Pattelli, Filippo Pecorari, Serena Perrella, Mario Piazzolla, Monica Portieri, Francesco Pugliese, Fabio Pulcinelli, Fabiola Ratini, Claudia Ricci, Franco Ruberto, Pietro Santopietro, Cristina Santoro, Alessandra Serrao, Guglielmo Tellan, Luca Titi, Paolo Tordiglione, Antonella Tosi, Fausto Trigilia |
| 174 |
[GO] |
2020―Jul―04 |
COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges |
Alfonso Piciocchi, Monica Messina, Stefano Soddu, Edoardo La Sala, Francesca Paoloni, Giorgia Giuliani, Martina Rachele Marino, Claudia Petrelli, Livia Gorreo Renzulli, Paola Fazi, Marco Vignetti |
| 175 |
[GO] |
2020―Jul―04 |
Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: Methodological issues and clinical implications |
Anastasios Kollias, Konstantinos G Kyriakoulis, George S Stergiou, Konstantinos Syrigos |
| 176 |
[GO] |
2020―Jul―01 |
ABO Phenotype and Death in Critically Ill Patients with COVID-19 |
Rebecca Karp Leaf, Hanny Al-Samkari, Samantha K. Brenner, Shruti Gupta, David E. Leaf |
| 177 |
[GO] |
2020―Jul―01 |
Concerns about how to use established minimal residual disease (MRD) monitoring in the treatment of NPM1
-mutant AML following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic |
Nadine Farah, Richard Burt, Amr R Ibrahim, Robert Baker, Panagiotis D Kottaridis |
| 178 |
[GO] |
2020―Jun―27 |
Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery |
E. Clark, P. Guilpain, L. Filip, N. Pansu, C. Le Bihan, G. Cartron, E. Tchernonog, Camille Roubille, D. Morquin, A. Makinson, E. Tuaillon, V. Le Moing |
| 179 |
[GO] |
2020―Jun―27 |
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection |
Andrew J Innes, Lucy B Cook, Sasha Marks, Edward Bataillard, Christina Crossette-Thambiah, Gayathiri Sivasubramaniam, Jane Apperley, Dragana Milojkovic |
| 180 |
[GO] |
2020―Jun―27 |
Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia |
J. Chopra, HJ. Hiew, A. Cumpstey, F. Cagampang, MW. Jenner, A. Dushianthan |
| 181 |
[GO] |
2020―Jun―25 |
Successful remission induction therapy with gilteritinib in a patient with
de novo FLT3
-mutated acute myeloid leukaemia and severe COVID-19 |
Andrew J. Wilson, Ethan Troy-Barnes, Maryam Subhan, Fiona Clark, Rajeev Gupta, Adele K. Fielding, Panagiotis Kottaridis, Marc R Mansour, Jenny O’Nions, Elspeth Payne, Naina Chavda, Robert Baker, Kirsty Thomson, Asim Khwaja |
| 182 |
[GO] |
2020―Jun―25 |
COVID-19 mortality in patients on anticoagulants and antiplatelet agents |
Helena Sivaloganathan, Eleni E Ladikou, Timothy Chevassut |
| 183 |
[GO] |
2020―Jun―25 |
Amelioration of COVID-19 related cytokine storm syndrome: Parallels to chimeric antigen receptor-T cell cytokine release syndrome |
Ryan L. Hoiland, Sophie Stukas, Jennifer Cooper, Sonny Thiara, Luke Y.C. Chen, Catherine M. Biggs, Kevin Hay, Agnes Y.Y. Lee, Kamran Shojania, Alym Abdulla, Cheryl L. Wellington, Mypinder S. Sekhon |
| 184 |
[GO] |
2020―Jun―25 |
Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer |
Sophie Portsmore, Thien Ngoc Tran Nguyen, Emma Beacham, Pratap Neelakantan |
| 185 |
[GO] |
2020―Jun―19 |
Haematological Cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date |
Dima El-Sharkawi, Sunil Iyengar |
| 186 |
[GO] |
2020―Jun―17 |
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19 |
Julien Maquet, Margaux Lafaurie, Agnès Sommet, Guillaume Moulis, Muriel Alvarez, Jacques Amar, Michel Attal, Laurent Balardy, Frédéric Balen, Odile Beyne-Rauzy, Ourdia Bouali, Fanny Bounes, Christophe Bureau, Louis Buscail, Lionel Calviere, Sandrine Charpentier, François Chollet, Isabelle Claudet, Arnaud Constantin, Alexa Debard, Karen Delavigne, Pierre Delobel, Julien Delrieu, Alain Didier, Marie Faruch, Olivier Fourcade, Bernard Georges, Etienne Grunenwald, Sophie Guyonnet, Hélène Hanaire, Christophe Hein, Nassim Kamar, Olivier Lairez, Pierre Mansat, Guillaume Martin-Blondel, Vincent Minville, Jérémie Pariente, Carle Paul, Pierre Payoux, Grégory Pugnet, Marie-Léa Piel-Julian, Christian Recher, Yves Rolland, Adeline Ruyssen-Witrand, Jean Sabatier, Laurent Sailler, Jean-Pierre Salles, Nicolas Sans, Marion Secher, Annick Sevely, Stein Silva, Claire Thalamas, Olivier Toulza |
| 187 |
[GO] |
2020―Jun―15 |
Rapid screening of COVID-19 patients by White blood cells scattergrams, a study on 381 patients |
Jennifer Osman, Jérome Lambert, Marie Templé, Floriane Devaux, Rémy Favre, Claire Flaujac, Delphine Bridoux, Stéphanie Marque-Juillet, Fabrice Bruneel, François Mignon, Ernesto Diaz-Flores, Véronique Hentgen, Alix Greder-Belan, Reza Azarian, Mehrsa Koukabi, Philippe Rousselot, Victoria Raggueneau, Benjamin Manéglier |
| 188 |
[GO] |
2020―Jun―12 |
C1-INH and the contact system in COVID-19 |
Timothy M Thomson, Emily Toscano, Ernesto Casis, Rosanna Paciucci |
| 189 |
[GO] |
2020―Jun―12 |
Haemophagocytosis in bone marrow aspirates in patients with COVID-19 |
Agathe Debliquis, Inès Harzallah, Joy Y. Mootien, Antoine Poidevin, Guylaine Labro, Amira Mejri, Mathilde Lamarque, Khaldoun Kuteifan, Bernard Drénou |
| 190 |
[GO] |
2020―Jun―11 |
Secondary HLH is uncommon in severe COVID-19 |
Henry Wood, John Jones, Kit Hui, Tracey Mare, Tasneem Pirani, James Galloway, Victoria Metaxa, Reuben Benjamin, Andrew Rutherford, Sharon Cain, Austin G Kulasekararaj |
| 191 |
[GO] |
2020―Jun―11 |
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience |
Vallari Shah, Thinzar Ko Ko, Mark Zuckerman, Jennifer Vidler, Sobia Sharif, Varun Mehra, Shreyans Gandhi, Andrea Kuhnl, Deborah Yallop, Daniele Avenoso, Carmel Rice, Robin Sanderson, Anita Sarma, Judith Marsh, Hugues de Lavallade, Pramila Krishnamurthy, Piers Patten, Reuben Benjamin, Victoria Potter, M. Mansour Ceesay, Ghulam J Mufti, Sam Norton, Antonio Pagliuca, James Galloway, Austin G Kulasekararaj |
| 192 |
[GO] |
2020―Jun―09 |
ITP flare with mild COVID-19 infection in pregnancy: A case report |
George Nesr, Catherine Garnett, Chris Bailey, Siamak Arami |
| 193 |
[GO] |
2020―Jun―09 |
Anti-A Isohemagglutinin titers and SARS-CoV2 neutralization: implications for children and convalescent plasma selection |
Daniele Focosi |
| 194 |
[GO] |
2020―Jun―04 |
Terminal complement inhibition dampens the inflammation during COVID-19 |
Austin G Kulasekararaj, Ioanna Lazana, Joanna Large, Kristina Posadas, Helen Eagleton, John Lord Villajin, Mark Zuckerman, Shreyans Gandhi, Judith CW Marsh |
| 195 |
[GO] |
2020―Jun―04 |
Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus |
Tarryn Lee Carlsson, Benjamin Walton, Graham Collin |
| 196 |
[GO] |
2020―Jun―02 |
Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19 |
Joseph A. Hippensteel, Ellen L. Burnham, Sarah E. Jolley |
| 197 |
[GO] |
2020―Jun―02 |
Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in β-Thalassemias: The Nationwide Iranian Experience |
Mehran Karimi, Sezaneh Haghpanah, Azita Azarkeivan, Zohreh Zahedi, Tahereh Zarei, Maryam Akhavan Tavakoli, Asghar Bazrafshan, Afshan Shirkavand, Vincezo De Sanctis |
| 198 |
[GO] |
2020―Jun―02 |
Re The source of elevated plasma D-dimer levels in COVID-19 infection |
Beverley J Hunt, Marcel Levi |
| 199 |
[GO] |
2020―Jun―01 |
A Case Series of MGUS and COVID-19 |
Jesus D. Gonzalez-Lugo, Lizamarie Bachier-Rodriguez, Mendel Goldfinger, Aditi Shastri, R. Alejandro Sica, Kira Gritsman, Vikas Mehta, Rafi Kabarriti, Sanjay Goel, Amit Verma, Ira Braunschweig, Noah Kornblum, Ioannis Mantzaris |
| 200 |
[GO] |
2020―Jun―01 |
Interleukin-6 Blockade Treatment for COVID-19 associated Cytokine Release Syndrome in a Patient with Poorly Controlled Chronic Myeloid Leukaemia |
Amita Ranger, Ruby Haji, Richard Kaczmarski, Akila Danga |
| 201 |
[GO] |
2020―Jun―01 |
Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic |
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Monique Minnema, Murielle Roussel, Arnaud Jaccard, Ute Hegenbart, Shaji Kumar, Maria Teresa Cibeira, Joan Blade, Meletios A. Dimopoulos |
| 202 |
[GO] |
2020―Jun―01 |
Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of severe COVID-19 patients |
Nadia Caccamo, Lucy C. Sullivan, Andrew G. Brooks, Francesco Dieli |
| 203 |
[GO] |
2020―Jun―01 |
Conquest of COVID-19. Publish it to Death? |
Robert Peter Gale |
| 204 |
[GO] |
2020―Jun―01 |
Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature |
Phil-Robin Tepasse, Wali Hafezi, Mathias Lutz, Joachim Kühn, Christian Wilms, Rainer Wiewrodt, Jan Sackarnd, Martin Keller, Hartmut H. Schmidt, Richard Vollenberg |
| 205 |
[GO] |
2020―May―29 |
Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience |
Alexandros Kanellopoulos, Maria Zahid Ahmed, Bhuvan Kishore, Richard Lovell, Claire Horgan, Paneesha Shankara, Rebecca Lloyd, Beena Salhan, Hannah Giles, Saleena Chauhan, Indrani Venkatadasari, Muhammad Khakwani, Vidhya Murthy, Evgenia Xenou, Hansini Dassanayake, Swathy Srinath, Maria Kaparou, Emmanouil Nikolousis |
| 206 |
[GO] |
2020―May―27 |
Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19) |
Emily Zagorski, Tushar Pawar, Shoja Rahimian, Daniel Forman |
| 207 |
[GO] |
2020―May―26 |
Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19) |
Wanxin Chen, Ziping Li, Bohan Yang, Ping Wang, Qiong Zhou, Zhiguo Zhang, Jianhua Zhu, Xuexing Chen, Peng Yang, Hao Zhou |
| 208 |
[GO] |
2020―May―26 |
COVID-19 and ABO blood group: another viewpoint |
Christiane Gérard, Gianni Maggipinto, Jean-Marc Minon |
| 209 |
[GO] |
2020―May―26 |
Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection |
Y Daniel, BJ Hunt, A Retter, K Henderson, S Wilson, CC Sharpe, MJ Shattock |
| 210 |
[GO] |
2020―May―26 |
Efficacy of therapeutic plasma exchange in severe COVID-19 patients |
Li Zhang, Hui Zhai, Shasha Ma, Jiasheng Chen, Yu Gao |
| 211 |
[GO] |
2020―May―26 |
Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? |
Francesca Angileri, Sébastien Légaré, Antonella Marino Gammazza, Everly Conway de Macario, Alberto J. L. Macario, Francesco Cappello |
| 212 |
[GO] |
2020―May―26 |
Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients |
Miguel D. Cantu, William S. Towne, Foxwell N. Emmons, Maria Mostyka, Alain Borczuk, Steven P. Salvatore, He S. Yang, Zhen Zhao, Ljiljana V. Vasovic, Sabrina E. Racine-Brzostek |
| 213 |
[GO] |
2020―May―23 |
Managing Sickle Cell Patients With COVID-19 Infection: The Need to Pool Our Collective Experience |
Kamal Kant Sahu, Ahmad Daniyal Siddiqui, Jan Cerny |
| 214 |
[GO] |
2020―May―21 |
Molecular mechanisms for thrombosis risk in black people: a role in excess mortality from Covid-19 |
Roshan amasamy, Kate M Milne, Simon M Stoneham, Timothy JT Chevassut |
| 215 |
[GO] |
2020―May―21 |
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy. |
Gordon Cook, A John Ashcroft, Guy Pratt, Rakesh Popat, Karthik Ramasamy, Martin Kaiser, Matthew Jenner, Sarah Henshaw, Rachel Hall, Jonathan Sive, Simon Stern, Matthew Streetly, Ceri Bygrave, Richard Soutar, Neil Rabin, Graham H Jackson |
| 216 |
[GO] |
2020―May―21 |
IL-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement |
James W. Day, Thomas A. Fox, Richard Halsey, Ben Carpenter, Panagiotis D. Kottaridis |
| 217 |
[GO] |
2020―May―20 |
Protective Role of BTK Inhibitors in Patients with Chronic Lymphocytic Leukemia and COVID-19 |
Santiago Thibaud, Douglas Tremblay, Sheena Bhalla, Brittney Zimmerman, Keith Sigel, Janice Gabrilove |
| 218 |
[GO] |
2020―May―20 |
High Fluorescent Lymphocytes Are Increased in COVID-19 Patients |
Zhao Wang, Yu He, Huaqing Shu, Ping Wang, Hui Xing, Xiaoqian Zeng, Zhaoming Tang |
| 219 |
[GO] |
2020―May―19 |
Covid-19 and Myeloma: what are the implications for now and in the future? |
Ciara L Freeman, Joseph Mikhael |
| 220 |
[GO] |
2020―May―19 |
Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum |
Isabel Farmer, Jumoke Okikiolu, Matthew Steel, Chandima Wanniarachchi, Shona Littlewood, Sunil Gupta, Muragaiyan Thanigaikumar, S. Helen Oram, Mal Moonim, Austin G Kulasekararaj, Tullie Yeghen |
| 221 |
[GO] |
2020―May―18 |
Atypical lymphocytes in peripheral blood of patients with COVID-19 |
Samuel E. Weinberg, Amir Behdad, Peng Ji |
| 222 |
[GO] |
2020―May―18 |
Evans syndrome in a patient with COVID-19 |
Monica Li, Charles B. Nguyen, Zachary Yeung, Katherine Sanchez, Daniel Rosen, Sita Bushan |
| 223 |
[GO] |
2020―May―18 |
The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants |
Shi-Qin Jiang, Qiu-Fen Huang, Wei-Ming Xie, Chao Lv, Xiao-Qing Quan |
| 224 |
[GO] |
2020―May―18 |
Patients with Sickle cell disease and suspected COVID-19 in a pediatric ICU |
C Heilbronner, L Berteloot, P Tremolieres, L Dupic, L De Saint Blanquat, F Lesage, M H Odièvre, C de Marcellus, J Fourgeaud, M de Montalembert, M Grimaud, F Moulin, S Renolleau, S Allali, M Oualha |
| 225 |
[GO] |
2020―May―18 |
Temporal Changes in Immune Blood Cell Parameters in COVID-19 Infection and Recovery from Severe Infection |
Christina YC Yip, Eng Soo Yap, Sanjay De Mel, Winnie Z.Y. Teo, Chun-Tsu Lee, Sheryl Kan, Chang Chuan Melvin Lee, Will NH Loh, Er Luen Lim, Shir Ying Lee |
| 226 |
[GO] |
2020―May―18 |
First Covid-19 maternal mortality in the UK associated with thrombotic complications |
Irshad Ahmed, Ahamed Azhar, Nashwa Eltaweel, Bee K Tan |
| 227 |
[GO] |
2020―May―18 |
Dynamic relationship between D-dimer and COVID-19 severity |
Yong Li, Kun Zhao, Hongcheng Wei, Wensen Chen, Wei Wang, Ling Jia, Qiongfang Liu, Jinpeng Zhang, Tao Shan, Zhihang Peng, Yun Liu, Xiaoxiang Yan |
| 228 |
[GO] |
2020―May―18 |
Successful prevention and screening strategies for COVID-19: focused on patients with hematologic diseases |
Sung-Yeon Cho, Sung-Soo Park, Ji-Young Lee, Hee-Je Kim, Yoo-Jin Kim, Chang-Ki Min, Bin Cho, Dong-Gun Lee, Dong-Wook Kim |
| 229 |
[GO] |
2020―May―18 |
Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients |
James A. Aries, Jeffrey K. Davies, Rebecca L. Auer, Simon L. Hallam, Silvia Montoto, Matthew Smith, Belen Sevillano, Vanessa Foggo, Bela Wrench, Krzysztof Zegocki, Samir Agrawal, Rifca Le Dieu, Edward Truelove, Thomas Erblich, Shamzah Araf, Jessica Okosun, Heather Oakervee, Jamie D. Cavenagh, John G. Gribben, John C. Riches |
| 230 |
[GO] |
2020―May―18 |
More on “Association between ABO blood groups and risk of SARS-CoV-2 Pneumonia” |
Jamie M. O’Sullivan, Soracha Ward, Helen Fogarty, James S. O’Donnell |
| 231 |
[GO] |
2020―May―13 |
More on COVID-19 Coagulopathy in Caucasian patients |
Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Paul Browne, Christopher L. Bacon, Richard Gaule, Alexander Gillett, Mary Byrne, Kevin Ryan, Niamh O’Connell, Jamie M. O’Sullivan, Niall Conlon, James S. O’Donnell |
| 232 |
[GO] |
2020―May―07 |
Survival study of hospitalized patients with concurrent Covid-19 and haematological malignancies |
Fernando Martín-Moro, Juan Marquet, Miguel Piris, Berta M Michael, Adolfo J Sáez, Magdalena Corona, Carlos Jiménez, Beatriz Astibia, Irene García, Eulalia Rodríguez, Carlota García-Hoz, Jesús Fortún-Abete, Pilar Herrera, Javier López-Jiménez |
| 233 |
[GO] |
2020―May―07 |
COVID-19 in a patient with pre-existing acute lymphoblastic leukemia |
Yinlian Wu, Heng Lin, Qiang Xie, Qun Chen, Yanfang Huang, Yueyong Zhu, Lizhou Chen |
| 234 |
[GO] |
2020―May―07 |
Outcome of a patient with refractory Hodgkin’s Lymphoma on pembrolizumab, infected with SARS-CoV-2 |
Brendan O’Kelly, Padraig McGettrick, Daniel Angelov, Michael P Fay, Tara McGinty, Aoife G Cotter, Gerard Sheehan, John S Lambert |
| 235 |
[GO] |
2020―May―07 |
Association between ABO blood groups and risk of SARS-CoV-2 pneumonia |
Juyi Li, Xiufang Wang, Jian Chen, Yi Cai, Aiping Deng, Ming Yang |
| 236 |
[GO] |
2020―May―06 |
Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis |
Daniel O. Griffin, Alexandra Jensen, Mushmoom Khan, Jessica Chin, Kelly Chin, Ryan Parnell, Christopher Awwad, Darshan Patel |
| 237 |
[GO] |
2020―May―06 |
Autoimmune hemolytic anemia associated with Covid-19 infection |
Gregory Lazarian, Anne Quinquenel, Mathieu Bellal, Justine Siavellis, Caroline Jacquy, Daniel Re, Fatiha Merabet, Arsene Mekinian, Thorsten Braun, Gandhi Damaj, Alain Delmer, Florence Cymbalista |
| 238 |
[GO] |
2020―May―06 |
Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic |
S. Pavord, J. Thachil, B. Hunt, M. Murphy, G. Lowe, M. Laffan, M. Makris, A. Newland, D. Provan, J. Grainger, Q. Hill |
| 239 |
[GO] |
2020―May―05 |
Concomitant hemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukemia |
Mathieu Baldacini, Raoul Pop, Laurent Sattler, Laurent Mauvieux, Karin Bilger, Justine Gantzer, Francis Schneider, Remy Beaujeux, Célestine Simand, Raoul Herbrecht |
| 240 |
[GO] |
2020―May―05 |
Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia |
Chris Lopez, Jeremy Kim, Apurva Pandey, Ted Huang, Thomas G. DeLoughery |
| 241 |
[GO] |
2020―May―05 |
IL-6 blockade treatment for severe COVID-19 in two patients with multiple myeloma |
Aristeidis Chaidos, Alexia Katsarou, Chira Mustafa, Dragana Milojkovic, Anastasios Karadimitris |
| 242 |
[GO] |
2020―May―05 |
COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience |
Kayleigh A. McCloskey, John Meenan, Rhys Hall, Dimitris A. Tsitsikas |
| 243 |
[GO] |
2020―May―05 |
Severe COVID-19 infection and thrombotic microangiopathy: success doesn't come easily |
Eleni Gavriilaki, Robert Alan Brodsky |
| 244 |
[GO] |
2020―May―05 |
Assessing the Impact of Lockdown: Fresh Challenges for the Care of Haematology Patients in the COVID-19 Pandemic |
John Willan, Andrew John King, Faouzi Djebbari, Gareth D.H. Turner, Daniel J. Royston, Sue Pavord, Graham P. Collins, Andy Peniket |
| 245 |
[GO] |
2020―May―05 |
Ph+ Acute Lymphoblastic Leukaemia in Italy During the Covid-19 Pandemic. A Campus ALL Study |
Robin Foà, Massimiliano Bonifacio, Sabina Chiaretti, Antonio Curti, Anna Candoni, Carmen Fava, Maria Ciccone, Giovanni Pizzolo, Felicetto Ferrara |
| 246 |
[GO] |
2020―May―05 |
Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease - has not received enough attention till date |
Brian Hanley, Candice A Roufosse, Michael Osborn, Kikkeri N Naresh |
| 247 |
[GO] |
2020―May―05 |
Thrombocytopenia as an initial manifestation of Covid-19; Case Series and Literature review |
Maria Zahid Ahmed, Muhammad Khakwani, Indrani Venkatadasari, Claire Horgan, Hannah Giles, Shailesh Jobanputra, Anand Lokare, Joanne Ewing, Paneesha Shankara, Vidhya Murthy |
| 248 |
[GO] |
2020―May―05 |
Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |
Elena Sieni, Francesco Pegoraro, Tommaso Casini, Annalisa Tondo, Barbara Bortone, Maria Moriondo, Chiara Azzari, Luisa Galli, Claudio Favre |
| 249 |
[GO] |
2020―May―05 |
SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies |
Matteo Molica, Carla Mazzone, Iole Cordone, Alessia Pasquale, Pasquale Niscola, Paolo de Fabritiis |
| 250 |
[GO] |
2020―Apr―30 |
Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19 |
Paul Vulliamy, Sabu Jacob, Ross A Davenport |
| 251 |
[GO] |
2020―Apr―24 |
COVID-19 Coagulopathy in Caucasian patients |
Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Paul Browne, Christopher L. Bacon, Richard Gaule, Alexander Gillett, Mary Byrne, Kevin Ryan, Niamh O'Connell, Jamie M. O'Sullivan, Niall Conlan, James S. O' Donnell |
| 252 |
[GO] |
2020―Apr―24 |
Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic |
Noémi BA Roy, Paul Telfer, Perla Eleftheriou, Josu de la Fuente, Emma Drasar, Farrukh Shah, David Roberts, Wale Atoyebi, Sara Trompeter, D. Mark Layton, Sanne Lugthart, Sara Stuart-Smith, Subarna Chakravorty, Josh Wright, John Porter, Baba Inusa, Jo Howard |
| 253 |
[GO] |
2020―Apr―21 |
COVID-19 Infection in Patients with Sickle Cell Disease |
Faiz A. Hussain, Franklin U. Njoku, Santosh L. Saraf, Robert E. Molokie, Victor R. Gordeuk, Jin Han |
| 254 |
[GO] |
2020―Apr―20 |
SARS-CoV-2: A new aetiology for atypical lymphocytes |
Delphine Gérard, Sylvain Henry, Benoît Thomas |
| 255 |
[GO] |
2020―Apr―18 |
Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis |
Mi Xiong, Xue Liang, You-Dong Wei |
| 256 |
[GO] |
2020―Apr―18 |
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action |
Anastasios Kollias, Konstantinos G Kyriakoulis, Evangelos Dimakakos, Garyphallia Poulakou, George S. Stergiou, Konstantinos Syrigos |
| 257 |
[GO] |
2020―Apr―16 |
Reactive lymphocytes in patients with Covid-19 |
Vanessa Cui Lian Chong, Eric Kian Guan Lim, Eugene Bingwen Fan, Stephrene Seok Wei Chan, Kiat Hoe Ong, Ponnudurai Kuperan |
| 258 |
[GO] |
2020―Apr―16 |
How we deal with the COVID-19 epidemic in an Italian pediatric onco-hematology clinic located in a region at high density of cases |
Laura Sainati, Alessandra Biffi |
| 259 |
[GO] |
2020―Apr―16 |
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients |
Suxin Wan, Qingjie Yi, Shibing Fan, Jinglong Lv, Xianxiang Zhang, Lian Guo, Chunhui Lang, Qing Xiao, Kaihu Xiao, Zhengjun Yi, Mao Qiang, Jianglin Xiang, Bangshuo Zhang, Yongping Chen, Cailiang Gao |
| 260 |
[GO] |
2020―Apr―16 |
Management of COVID-19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory |
Joyce Ching Mei Lam, Grace Benjamin Moshi, Soh Hong Ang, Hui Ming Chew, Qing Hui Ng, Andrew Madjukie, Logeswary M |
| 261 |
[GO] |
2020―Apr―14 |
The proportion of patients with thrombocytopenia in three human-susceptible coronavirus infections: a systematic review and meta-analysis |
Meng Zhou, Jiaqian Qi, Xueqian Li, Ziyan Zhang, Yifang Yao, Depei Wu, Yue Han |
| 262 |
[GO] |
2020―Apr―13 |
Editorial - COVID-19 |
John Barret |
| 263 |
[GO] |
2020―Mar―17 |
How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat? |
Bhagirathbhai Dholaria, Bipin N. Savani |
| 264 |
[GO] |
2020―Mar―16 |
Care of haematology patients in a COVID-19 epidemic |
John Willan, Andrew J. King, Sandy Hayes, Graham P. Collins, Andrew Peniket |
|
